Jefferies upgrades Zydus Life to ‘Buy’ on strong US pipeline potential, stock up 4%
Global brokerage firm Jefferies has upgraded Zydus Lifesciences to a ‘Buy’ rating, citing the strength of the companyβs US pipeline as a key driver for future growth. The brokerage raised its target price for the stock to Rs 1,450 from the previous Rs 1,210, reflecting a 30% upside potential from the previous day’s closing price…
READ MORE
India will remain top choice for private equity investments despite external shocks: Jefferies
New Delhi [India], August 9 (ANI): Global brokerage firm Jefferies in its latest report identifies India as a prime market for listing private equity (PE) investments, suggesting a huge pipeline for investment bankers globally. The report noted that despite the challenges faced by the private equity industry, including a liquidity squeeze and declining distributions from…
READ MORE
ITC: Budget does not singe ITC with tax hike, shares top Rs 500-mark
Mumbai: ITC shares crossed the βΉ500 mark for the first time on Wednesday after the budget left tobacco taxation unchanged. Analysts recommend buying the stock on any dip for a short-term return of up to 15%. After the budget, global brokerage Jefferies upgraded the stock from hold to buy and raised the target price to…
READ MORE